American Financial Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-60,000
Closed -$5.96M 144
2019
Q3
$5.96M Hold
60,000
0.49% 56
2019
Q2
$5.55M Hold
60,000
0.45% 56
2019
Q1
$5.66M Sell
60,000
-40,000
-40% -$3.5M 0.5% 59
2018
Q4
$6.41M Buy
100,000
+50,000
+100% +$3.69M 0.6% 53
2018
Q3
$4.47M Buy
50,000
+25,000
+100% +$2.21M 0.44% 59
2018
Q2
$1.99M Hold
25,000
0.19% 87
2018
Q1
$2.23M Hold
25,000
0.21% 80
2017
Q4
$2.61M Hold
25,000
0.28% 71
2017
Q3
$3.65M Hold
25,000
0.38% 63
2017
Q2
$3.25M Hold
25,000
0.31% 68
2017
Q1
$3.11M Hold
25,000
0.29% 70
2016
Q4
$2.89M Hold
25,000
0.28% 71
2016
Q3
$2.61M Hold
25,000
0.19% 78
2016
Q2
$2.46M Hold
25,000
0.19% 81
2016
Q1
$2.5M Hold
25,000
0.19% 78
2015
Q4
$2.99M Hold
25,000
0.23% 78
2015
Q3
$2.71M Hold
25,000
0.2% 87
2015
Q2
$2.89M Hold
25,000
0.24% 78
2015
Q1
$2.88M Hold
25,000
0.23% 79
2014
Q4
$2.8M Sell
25,000
-35,000
-58% -$3.69M 0.22% 78
2014
Q3
$5.69M Hold
60,000
0.47% 62
2014
Q2
$5.15M Buy
+60,000
New +$4.56M 0.42% 65

Other funds holding CELG

American Financial Group's CELG Position: Q4 2019 in Review

American Financial Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 60,000 shares — an estimated $5.96M sold.

American Financial Group first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $6.41M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • American Financial Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • American Financial Group sold 60,000 Celgene Corp shares in Q4 2019, an estimated $5.96M.
  • American Financial Group first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • American Financial Group's Celgene Corp position peaked at $6.41M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on American Financial Group's 13F filing for Q4 2019, filed 11 Feb 2020.